Egor A. Makarov

Egor A. Makarov

Auto-generated profile, based on publicly available information

Egor A. Makarov

Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2021 in Russian Open Medical Journal
Verified
Journal Article
Closed access
DSDiana K. Sarkisian
Diana K. Sarkisian
NCNatalia V. Chebotareva
Natalia V. Chebotareva
VMValerie McDonnell
Valerie McDonnell
AOArmen V. Oganesyan
Armen V. Oganesyan
TKTatyana N. Krasnova
Tatyana N. Krasnova
EMEgor A. Makarov
Egor A. Makarov
Background — Acute kidney injury (AKI) reaches 29% in the intensive care unit (ICU). Our study aimed to determine the prevalence, features, and the main AKI factors in critically ill patients with coronavirus disease 2019 (COVID-19). Material and Methods — The study included 37 patients with COVID-19. We analyzed the total blood count test results, biochemical profile panel, coagulation tests, and urine samples. We finally estimated the markers of kidney damage and mortality. Result — All patients in ICU had proteinuria, and 80.5% of patients had hematuria. AKI was observed in 45.9% of patients. Independent risk factors were age more than 60 years, increased C-reactive protein (CRP) level, and decreased platelet count. Conclusion — Kidney damage was observed in most critically ill patients with COVID-19. The independent risk factors for AKI in critically ill patients were elderly age, a cytokine response with a high CRP level.

20 December 2023 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
OGO. A. Georginova
O. A. Georginova
NGN. N. Goncharova
N. N. Goncharova
EGE. A. Grishanina
E. A. Grishanina
SZS. A. Zakharova
S. A. Zakharova
EME. A. Makarov
E. A. Makarov
TKT. N. Krasnova
T. N. Krasnova
The article provides a description of the anthropological finding – human remains discovered in the church of St. Peter (Domashevo, Bosnia and Herzegovina, burial at the turn of the 15th and 16th centuries AD). The available morphological data most likely indicate the presence of diffuse idiopathic skeletal hyperostosis. This disease resulted in trauma to the cervical vertebrae, which altered their morphology. However, the injury did not lead to death; the person lived for a long time afterwards, as post-traumatic skeletal changes with the development of torticollis were noted.

15 December 2018 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
EME. A. Makarov
E. A. Makarov
HNH. I. Novikov
H. I. Novikov
AZA. S. Zykova
A. S. Zykova
TKT. N. Krasnova
T. N. Krasnova
ABA. V. Balatskiy
A. V. Balatskiy
NMN. A. Moukhin
N. A. Moukhin
The rate of venous thromboembolic events (VTE) is high in patients with ANCA-associated vasculitides (AAV), but risk factors are unclear. Material and methods. In 85 patients with AAV we performed routine clinical assessment and detected genetic mutations, associated with thrombophilia by real time polymerase chain reaction. Results. The polymorphism ofmethylenetetrahydrofolate reductase gene (MTHFR 677 C/T) is associated with lung involvement (р=0,007, OR 4,305 (95% CI 1,547-11,983), polymorphism FXIII 103 G/T is associated with higher VDI - 6,0 (4,0; 8,0) и and earlier disease onset. Combined impact of integrin А2 (ITGA2 807 C/T), plasminogen activator inhibitor-1 (PAI-1 675 5G4G), fibrinogen (FGB 455 G/A) and FV (FV 1691 G/A) polymorphism effects on VTE development in patients with AAV (p=0,007). Conclusion. Thrombophilia genes may be considered as risk factors of VTE in patients with AAV.

19 March 2026 in Journal of Clinical Practice
Verified
Journal Article
Open access
EGEkaterina A. Grishanina
Ekaterina A. Grishanina
OGOlga A. Georginova
Olga A. Georginova
AMAntonina A. Michurina
Antonina A. Michurina
EMEgor A. Makarov
Egor A. Makarov
VAVladimir G. Avdeev
Vladimir G. Avdeev
ESElena М. Seredenina
Elena М. Seredenina
A clinical case of patient with systemic scleroderma, which began with a three-phase Raynaud’s phenomenon, confirmed by capillaroscopy is described. The disease developed after long-term professional contact with pesticides used to control rodents. Clinicians should not neglect information about the patient's place of work in order to promptly identify occupational pathology and eliminate pathogenic factors leading to the development of systemic autoimmune diseases.

18 January 2024 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
OGOlga A. Georginova
Olga A. Georginova
EMEgor A. Makarov
Egor A. Makarov
ABAnton A. Budko
Anton A. Budko
VAVladimir G. Avdeev
Vladimir G. Avdeev
RGRoman M. Gorbunov
Roman M. Gorbunov
TKTatiana N. Krasnova
Tatiana N. Krasnova
We describe a clinical observation of a 64-year old Caucasian patient with a longstanding ankylosing spondylitis, who was admitted to the clinic for diarrhea and joint syndrome. Physical and X-ray examination showed that his musculoskeletal system disorder was represented by ankylosing spondylitis, symmetrical erosive polyarthritis of the metacarpophalangeal joints, and wrist joint ankylosis. Laboratory work-up identified that the patient was HLA-B27 positive, had high rheumatoid factor and anti-citrulline antibodies levels. At colonoscopy, there were signs of ulcerative colitis. After the differential diagnosis procedures, we were able to conclude that the patient had a combination of rheumatoid arthritis, ankylosing spondylitis, and ulcerative colitis as three independent but associated disorders. The first description of these three autoimmune diseases in one patient can be of interest for clinicians.

26 September 2026 in Nephrology and Dialysis
Verified
Journal Article
Open access
PDF file
NBNikolay Bulanov
Nikolay Bulanov
EME. A. Makarov
E. A. Makarov
MLM. A. Litvinova
M. A. Litvinova
ASA. V. Skvortsov
A. V. Skvortsov
ESE. M. Shchegoleva
E. M. Shchegoleva
СМС. В. Моисеев
С. В. Моисеев
Objective: to assess the prevalence of chronic kidney disease (CKD) stages and to identify factors associated with progression to advanced CKD stages in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Materials and Methods: this bidirectional cohort study enrolled adult patients with AAV who were hospitalized at least once between 2010 and 2025 and were subsequently followed on an inpatient and/or outpatient basis. Kidney involvement associated with AAV was confirmed by kidney biopsy or, if unavailable, by the presence of manifestations within the renal domain of the Birmingham Vasculitis Activity Score (BVAS v.3). The primary endpoint was CKD stage at the end of follow-up, defined according to the KDIGO 2024 guidelines. Risk stratification for adverse CKD outcomes also followed the KDIGO 2024 guidelines. Multivariable ordinal logistic regression was conducted to identify factors associated with advanced CKD stages, with results reported as odds ratios (ORs) and 95% confidence intervals (CIs). Results: a total of 706 patients were included. Kidney involvement was identified at any time during follow-up in 58.6% (95% CI 54.9-62.3%). The median (interquartile range, IQR) age at AAV diagnosis was 50 (36-60) years, and the median follow-up duration was 54 (15-101) months. CKD staging was performed in 673 patients. Among 395 patients with AAV and kidney involvement, advanced CKD stages (G4–G5) were diagnosed in 29.9% (95% CI 25.4-34.7%), and 60% (95% CI 55.0-64.9%) were stratified into high or very high risk for adverse outcomes. Among 278 patients who did not develop AAV-related kidney involvement at any time during follow-up, CKD developed in 24.8% (95% CI 19.9-30.3%), including CKD G4 in 0.7% (95% CI 0.1-2.6%), and 3.2% (95% CI 1.5-6.1%) were stratified into high or very high risk. Multivariable ordinal logistic regression identified dialysis dependence at diagnosis (OR 2.54, 95% CI 1.22-5.33), isolated renal involvement in AAV (OR 2.04, 95% CI 1.03-4.06), and arterial hypertension (OR 3.70, 95% CI 2.17-6.31) as factors associated with advanced CKD. A preserved eGFR at diagnosis (OR 0.66, 95% CI 0.61-0.72 per 10 mL/min increment) and achievement of renal remission within four months (OR 0.13, 95% CI 0.07-0.24) were associated with a lower probability of advanced CKD. Conclusion: reduced baseline eGFR, dialysis dependence at diagnosis, arterial hypertension, and failure to achieve renal remission are the primary factors independently associated with progression to advanced CKD stages in patients with AAV.